In the coming days, the Commission will launch the interim evaluation of the two FET Flagships, the Human Brain Project (HBP) and Graphene. The evaluation will be held by a panel of high-level experts. Their goal will be to analyse the capability of the Flagships in delivering their long-term objectives. The recommendations of the evaluation panel will help fine-tuning the current implementation of the Flagships and their governance model and pave the way for future FET Flagships.
New technologies have a huge positive impact on human lives. Already today, mechanical limbs connected to the nervous system and exoskeletons – innovative devices that impaired people wear in order to support their mobility and dexterity – can enhance physical performance and help by-pass disability. BNCIs (brain-neural computer interfaces) help people with severe disabilities regain control over everyday life; participate in society, and work.
This is why we support new technologies. And we will keep on doing it.
High pressure in the pharmaceutical industry to decrease development time and costs has led to significant advancements to improve pre-clinical drug assessment. The “Body on a Chip”(BoC) develops interconnected 3D microtissues in a format compatible with existing assays to improve the relevance and speed of pre-clinical drug safety assessment.
The European Graphene Flagship project starts delivering and shows its wonders at the European Parliament where the think tank STOA hosted a workshop with a special guest, the Nobel Prize Laureate, Novoselov
The Human Brain Project Flagship call for systems and cognitive neuroscience community to join the project's next phase, under Horizon 2020
Recent developments in non-invasive brain stimulation and its application in cognitive enhancement.